IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
Study Objective: Compare longitudinal HIV-1 antibody responses among HIV-1 infected participants that either did or did not...
